Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism

Journal of Neural Transmission

Volumn 104, Issue 10, 1997, Pages 1113-1123

  Maggio, R ^a   Riva, M ^b,c   Vaglini, F ^a   Fornai, F ^a   Racagni, G ^b   Corsini, G U ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Neuroprotection; Neurotrophic factor; Nicotine; Parkinsonism

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ACETYLCHOLINE; BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; DIETHYLDITHIOCARBAMIC ACID; ION CHANNEL; METHAMPHETAMINE; NEUROTROPHIC FACTOR; NICOTINE; RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CENTRAL NERVOUS SYSTEM; CIGARETTE SMOKING; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RAT; RISK; SUBCUTANEOUS DRUG ADMINISTRATION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; DOPAMINE UPTAKE INHIBITORS; FIBROBLAST GROWTH FACTOR 2; MALE; MESENCEPHALON; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; NEOSTRIATUM; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NICOTINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE;

EID: 0031434470     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01273324     Document Type: Conference Paper

References (30)

1. Aizenman E, Lian-Hong T, Reynolds IJ (1991) Effects of nicotinic agonists on the NMDA receptor. Brain Res 551: 355-357
2. Asai T, Wanaka A, Kato H, Masana Y, Seo M, Tohyama M (1993) Differential expression of two members of FGF receptor gene family, FGFR-1 and FGFR-2 mRNA, in the adult rat central nervous system. Mol Brain Res 17: 174-178
3. Baron JA (1986) Cigarette smoking and Parkinson's disease. Neurology 36: 1490-1495
4. Bean AJ, Elde R, Cao Y, Oellig C, Tamminga C, Goldstein M, Pettersson RF, Hoxfelt T (1991) Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey and human. Proc Natl Acad Sci USA 88: 10237-10241
5. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80: 4546-4550
6. Cintra A, Cao Y, Oellig C, Tinner B, Bortolotti R, Pettersson RF, Fuxe K (1991) Basic FGF is present in dopaminergic neurons of the ventral midbrain of the rat. NeuroReport 2: 597-600
7. Conti-Tronconi BM, McLane KE, Raftery MA, Grando SA, Protti MP (1994) The nicotinic acetylcholine receptor: structure and autoimmune pathology. Crit Rev Biochem Mol Biol 29: 69-123
8. Corsini GU, Pintus S, Chiueh CC, Weiss JF, Kopin IJ (1985) 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate. Eur J Pharmacol 119: 127-128
9. Fornai F, Vaglini F, Maggio R, Bonuccelli U, Corsini GU (1996) Excitatory amino acids and MPTP toxicity. Adv Neurol 69: 167-176
10. Fowler JS, Volkow ND, Wang G-J, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cliento R (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379: 733-736
11. Hefti FJ (1994) Neurotrophic factor therapy for nervous system degenerative diseases. Neurobiology 25: 1418-1435
12. Hotchkiss AJ, Gibb JW (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214: 257-262
13. Jackson DM, Westind-Danielsson A (1994) Pharmacol Ther 64: 291-369
14. Langston JW, Ballard PA, Tetrud JW, Irwin I (1983) Chronic parkinsonism in human due to a product of meperidine-analog synthesis. Science 219: 979-980
15. Lees AJ on behalf of the Parkinson's Disease Research Group of the United Kingdom (1995) Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Br Med J 311: 1602-1607
16. Marin P, Maus M, Desagher S, Glowinski J, Prémont J (1994) Nicotine protects cultured striatal neurons against N-methyl-D-aspartate receptor-mediated neurotoxicity. NeuroReport 5: 1977-1980
17. McGeer EG, Singh EA, McGeer PL (1992) Apparent anterograde transport of basic fibroblast growth factor in the rat nigrostriatal dopamine system. Neurosci Lett 148: 31-33
18. Morens DM, Grandinetti A, Reed D, White LR, Ross GW (1995) Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue? Neurology 45: 1041-1051
19. Muraki A, Koyama T, Nakayama M, Ohmori T, Yamashita I (1992) MK-801, a non-competitive antagonist of NMDA receptor prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum. Neurosci Lett 136: 39-42
20. Otto D, Unsicker K (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10: 1912-1921
21. Parkinson's Study Group (1989) Effects of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 321: 1364-1371
22. Sidman RL, Angevine Jr JB, Taber Pierce E (1971) Atlas of the mouse brain and spinal cord. Harvard University Press
23. Sonsalla PK, Nicklas WJ, Heikkila RE (1989) Role for excitatory amino acids in methamphetamine induced nigrostriatal dopaminergic toxicity. Science 243: 398-400
24. Sonsalla PK, Riordan DE, Heikkila RE (1991) Competitive and noncompetitive antagonist at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J Pharmacol Exp Ther 256: 506-512
25. Tetrud JW, Langston JW (1989) The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. Science 245: 519-522
26. Tooyama I, Kawamata T, Walker D, Yamada T, Hanai K, Kimura H, Iwane M, Igarashi K, McGeer EG, McGeer PL (1993) High molecular weight basic fibroblast growth factor-like protein is localized to a subpopulation of mesencephalic dopaminergic neurons in the rat brain. Neurology 43: 372-376
27. Vaglini F, Fascetti F, Fornai F, Maggio R, Corsini GU (1994) (+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice. Brain Res 668: 194-203
28. Vaglini F, Pardini C, Cavalletti M, Maggio R, Corsini GU (1995) L-Deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion. Brain Res 674: 127-132
29. Wagner GC, Ricarute GA, Seiden LS, Schuster CR, Miller JM, Westly J (1980) Long-lasting depletion of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 171: 151-160
30. Wanaka A, Johnson EM, Milbrandt J (1990) Localization of FGF receptor mRNA in the adult rat central nervous system by in situ hybridization. Neuron 5: 267-281